6 Recruiting Recurrent Lung Non-Small Cell Carcinoma Phase 2 Clinical Trials
Active phase 2 studies for recurrent lung non-small cell carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Recurrent Lung Non-Small Cell Carcinoma studiesPhase 2 Studies for Recurrent Lung Non-Small Cell Carcinoma
🔵 Active, Not Recruiting Phase2
Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
View Study & Checklist ➔